Alloonc
2013
FOUNDED
PRIVATE
STATUS
Accelerator/Inc
LATEST DEAL TYPE
1
INVESTORS
Description
Operator of a biotechnology company intended to develop cellular therapeutic invention to cure cancer. The company's product, Mesenkiller uses a molecule which targets cancer cells that is linked with a radioactive particle killing both targeted and the surrounding non targeted cells, enabling cancer patients with efficient and effective therapeutic without having any systemic affects on the body.
Website
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Primary Office
- 1396 Milano Drive Unit 3
- West Sacramento, CA 95691
- United States
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Alloonc’s full profile, request a free trial.
Alloonc Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Clinical Trials - Phase 1 |
Alloonc Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| California Institute for Quantitative Biosciences | Accelerator/Incubator | 000 0000 | 000000 0 |